Progranulin Levels in Plasma and Cerebrospinal Fluid in Granulin Mutation Carriers

Progranulin Levels in Plasma and Cerebrospinal Fluid in Granulin Mutation Carriers

Background: Pathogenic mutations in the granulin gene (GRN) are causative in 5-10% of patients with frontotemporal dementia (FTD), mostly leading to reduced progranulin protein (PGRN) levels. Upcoming therapeutic trials focus on enhancing PGRN levels. Methods: Fluctuations in plasma PGRN (n = 41) an...

Full description

Bibliographic Details
Main Authors: Lieke H.H. Meeter, Holger Patzke, Gordon Loewen, Elise G.P. Dopper, Yolande A.L. Pijnenburg, Rick van Minkelen, John C. van Swieten
Format: Article
Language:English
Published: Karger Publishers 2016-07-01
Series:Dementia and Geriatric Cognitive Disorders Extra
Subjects:
Frontotemporal dementia
Progranulin protein
Granulin gene (GRN)
Plasma
Cerebrospinal fluid
Biomarker
Single nucleotide polymorphism
Online Access:http://www.karger.com/Article/FullText/447738

Internet

http://www.karger.com/Article/FullText/447738

Similar Items